Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose ; volume:16 ; number:1 ; day:26 ; month:4 ; year:2018 ; pages:1-11 ; date:12.2018
Journal of translational medicine ; 16, Heft 1 (26.4.2018), 1-11, 12.2018
- Creator
-
O’Leary, Michael P.
- Contributor
-
Choi, Audrey H.
Kim, Sang-In
Chaurasiya, Shyambabu
Lu, Jianming
Park, Anthony K.
Woo, Yanghee
Warner, Susanne G.
Fong, Yuman
Chen, Nanhai G.
SpringerLink (Online service)
- DOI
-
10.1186/s12967-018-1483-x
- URN
-
urn:nbn:de:101:1-2018063019021133359542
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- O’Leary, Michael P.
- Choi, Audrey H.
- Kim, Sang-In
- Chaurasiya, Shyambabu
- Lu, Jianming
- Park, Anthony K.
- Woo, Yanghee
- Warner, Susanne G.
- Fong, Yuman
- Chen, Nanhai G.
- SpringerLink (Online service)
Other Objects (12)
Oncolytic tanapoxvirus expressing FliC causes regression of human colorectal cancer xenografts in nude mice
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Protein dynamics in responder and non-responder solid tumor xenografts during oncolytic viral therapy
Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy
Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasms
Oncolytic therapy with vaccinia virus GLV-1h68 : comparative microarray analysis of infected xenografts and human tumor cell lines
Exhibits
Exhibits
A 90Y-labelled anti-ROBO1 monoclonal antibody exhibits antitumour activity against hepatocellular carcinoma xenografts during ROBO1-targeted radioimmunotherapy
Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68
Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68
Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression
Oncolytic tanapoxvirus expressing FliC causes regression of human colorectal cancer xenografts in nude mice
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Protein dynamics in responder and non-responder solid tumor xenografts during oncolytic viral therapy
Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy
Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasms
Oncolytic therapy with vaccinia virus GLV-1h68 : comparative microarray analysis of infected xenografts and human tumor cell lines
Exhibits
Exhibits
A 90Y-labelled anti-ROBO1 monoclonal antibody exhibits antitumour activity against hepatocellular carcinoma xenografts during ROBO1-targeted radioimmunotherapy
Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68
Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68
Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression
Oncolytic tanapoxvirus expressing FliC causes regression of human colorectal cancer xenografts in nude mice
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Protein dynamics in responder and non-responder solid tumor xenografts during oncolytic viral therapy
Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy
Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasms
Oncolytic therapy with vaccinia virus GLV-1h68 : comparative microarray analysis of infected xenografts and human tumor cell lines
Exhibits
Exhibits
A 90Y-labelled anti-ROBO1 monoclonal antibody exhibits antitumour activity against hepatocellular carcinoma xenografts during ROBO1-targeted radioimmunotherapy
Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68
Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68